NCT00717145View on ClinicalTrials.gov

Food Effects on the Relative Bioavailability of Different Dosages of Risedronate

PHASE1CompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
PostmenopausalNon-lactatingSurgically Sterile
Interventions
DRUG

risedronate

one risedronate 20 mg DR tablet

DRUG

risedronate

One risedronate 20 mg DR tablet

DRUG

risedronate

One risedronate 35 mg DR tablet

DRUG

risedronate

One risedronate 35 mg IR tablet

Trial Locations (3)

Unknown

Research Site, Gainesville

Research site, Miramar

Research Site, Austin

Sponsors

Lead Sponsor

Warner Chilcott

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Warner Chilcott

INDUSTRY